← Back to news
Y

Yahoo Finance

3 Dividend Stocks to Double Up on Right Now

Y

Nvidia's stock market value hits $4 trillion on AI dominance

Y

O Canada! How Much Lower Will Canadian Dollar Futures Go From Here?

Y

Mortgage Applications Jump As Loan Rates Dip

Y

UK small business growth forecasts hit lockdown levels: Novuna

Y

Microsoft upgraded, Instacart initiated: Wall Street's top analyst calls

Y

This Underdog AI Stock Just Got a New Street-High Price Target

Y

Globalstar Nabs a SpaceX Deal. How Should You Play GSAT Stock Now?

Y

Tesla sell-off is overdone, this bull says

Y

SoFi Technologies Hits Another 52-Week High: Is It a $20, $40, or $10 Stock?

Y

Okta and 2 Other Software Stocks That Provide Shelter From Tariffs

Y

Taim launches franchising in challenge to Cava

Y

9 Great Notes About Financial Freedom With Motley Fool Co-Founder David Gardner

Y

Morrisons enhances store navigation with AI-powered product finder

Y

Got Money Stress? These 5 Financial Habits Can Help You Feel More in Control

Y

Global banks predicted to get 10% trading revenue boost on tariff turmoil

Y

Why Standard Chartered Says H2 2025 Will Be 'Bitcoin's Best Ever'

Y

Bit Digital Is Going All in on Ethereum. Should You Buy BTBT Stock Here?

Y

Warburg Predicts Comparable US Tariffs Across Asean Markets

Y

FXPrimus Launches Synthetic Indices - Setting a New Standard for High-Intensity, High-Risk Trading

Y

Hershey (HSY) to Get Rid of Artificial Colors in Snack by 2027

Y

American Electric Power Company (AEP) Bolsters Management Team

Y

Duke Energy’s (DUK) Subsidiary Eyes More Revenues in South Carolina

Y

Novo Nordisk Receives Boost on $2.34B Italian Factory

Y

UBS Affirms Merck & Co’s (MRK) ‘Buy’ Rating on HPV Vaccine Prospects

Y

Diageo PLC (DEO) Expands Premium Product Portfolio with Casamigos Margaritas

Y

Comcast (CMCSA) Positioned for Resilience and Growth Amid Market Volatility and U.S. Tax Tailwinds

Y

BofA Securities Reiterates ‘Neutral’ Rating on T-Mobile (TMUS)

Y

Oppenheimer Reiterates ‘Outperform’ Rating on Abbott Laboratories (ABT)

Y

AstraZeneca PLC (AZN) Partners Modella AI for AI Drug Development

Y

Stocks and Bonds Disagree on the Economy—Again. They Both Can’t Be Right.

Y

Apple Needs Acquisition To Catch Up In AI Race, Analyst Says

Y

Espersen confirms plan to close UK seafood factory, affecting 115 jobs

Y

RxSight Stock Sinks 50% as Medical Device Maker Slashes Revenue Outlook

Y

Merck Plots $10 Billion Takeover Of COPD Drugmaker Verona Pharma

Y

Can Oracle Stock Take out $275 in 2025?

Y

The AI Scraping Fight That Could Change the Future of the Web

Y

Crypto Exchange Bullish Teams Up With Solana for Institutional Stablecoin Push

Y

Carson Group Goes On Acquisition Spree, Buys 15th RIA This Year

Y

Alvotech expands biosimilars capabilities with Ivers-Lee acquisition

Y

Nvidia (NVDA) Involved in Nearly Every Sovereign AI Deal — Citi Raises Price Target

Y

Meta’s Long-Term AI Vision Gains Support — But EU Rules and Competition Loom

Y

UBS Keeps $210 Target on Apple (AAPL) — China Still Key in Supply Chain

Y

HSBC Maintains ‘Reduce’ on Tesla (TSLA)— Warns June Run Rate Isn’t the New Normal

Y

Why Bernstein Is Bullish on Oracle’s (ORCL) Multi-Cloud and AI Strategy

Y

Oil Steadies as Traders Weigh Bearish US Data Against Sanctions

Y

Truist Maintains Hold on AMD Amid Datacenter GPU Debate

Y

Analyst: Snowflake (SNOW)’s AI Breakthroughs Could Power Long-Term Growth

Y

Datadog (DDOG) Joins S&P 500 — TD Cowen Reiterates Buy Rating

Y

CrowdStrike (CRWD) Downgraded by Piper Sandler Despite Long-Term AI Potential

Y